Want to see FR:LTA full AI Analyst Report?
LTA Stock Chart & Stats
€29.50
€0.10(0.43%)
At close: 4:00 PM EST
€29.50
€0.10(0.43%)
Day’s Range― - ―
52-Week Range€22.50 - €30.80
Previous CloseN/A
Volume420.00
Average Volume (3M)925.00
Market Cap
€868.99M
Enterprise Value€921.18M
Total Cash (Recent Filing)€20.08M
Total Debt (Recent Filing)€72.45M
Price to Earnings (P/E)―
Beta0.07
Next Earnings
Sep 03, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.56%
Share Statistics
EPS (TTM)-1.68
Shares Outstanding36,512,302
10 Day Avg. Volume1,554
30 Day Avg. Volume925
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)0.93
Price to Sales (P/S)-15.31
P/FCF Ratio149.66
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.16
Revenue Forecast (FY)€46.20M
Bulls Say, Bears Say
Bulls Say
Strong Balance SheetA sizeable equity base and minimal leverage provide durable financial flexibility: Altamir can absorb private-asset valuation swings, support continued commitments to funds and co-investments, and face market stress without urgent refinancing needs. Zero reported debt in 2025 materially lowers near-term liquidity and covenant risk and supports capital allocation optionality over the coming months.
Diversified Private Equity ExposureAltamir’s model of diversified commitments across strategies, managers and geographies reduces reliance on any single sector or deal outcome. This structural diversification smooths return volatility at the portfolio level, preserves access to multiple sources of distributions and capital gains, and supports resilience in varying market cycles over a 2–6 month horizon and beyond.
Demonstrated Cash Generation CapacityThe sizable free cash flow achieved in 2024 shows the company can realize cash from its private equity investments when market conditions permit, enabling distributions, reinvestment or shareholder returns. This ability to convert NAV into cash in favorable periods is a durable capability that supports liquidity planning and capital deployment strategy.
Bears Say
Highly Volatile EarningsPronounced swings between profit and loss undermine predictability of earnings and reported NAV. Such volatility complicates forecasting of distributable cash and can limit management’s ability to commit to new funds or sustain dividends. Persistent earnings instability also raises investor scrutiny and makes multi-quarter planning and capital allocation more challenging.
Inconsistent Cash ConversionIrregular cash generation reduces the company’s ability to reliably fund distributions, co-investments or operational needs without depending on new realizations or external financing. This uneven conversion from reported gains to cash increases liquidity risk in adverse markets and constrains durable capital allocation decisions over the medium term.
Profitability Swings Can Erode Book ValueLarge negative results can materially reduce equity backing and NAV reported to shareholders. If losses persist or lead to markdowns of underlying holdings, book value erosion would limit options for dividends, buybacks or capital raises, and could force a reorientation of portfolio strategy to stabilize shareholder equity.
LTA FAQ
What was ALTAMIR’s price range in the past 12 months?
ALTAMIR lowest stock price was €22.50 and its highest was €30.80 in the past 12 months.
What is ALTAMIR’s market cap?
ALTAMIR’s market cap is €868.99M.
When is ALTAMIR’s upcoming earnings report date?
ALTAMIR’s upcoming earnings report date is Sep 03, 2026 which is in 50 days.
How were ALTAMIR’s earnings last quarter?
ALTAMIR released its earnings results on Mar 12, 2026. The company reported -€1.221 earnings per share for the quarter, missing the consensus estimate of N/A by -€1.221.
Is ALTAMIR overvalued?
According to Wall Street analysts ALTAMIR’s price is currently Overvalued.
Does ALTAMIR pay dividends?
ALTAMIR pays a Annually dividend of €1.06 which represents an annual dividend yield of 3.56%. See more information on ALTAMIR dividends here
What is ALTAMIR’s EPS estimate?
ALTAMIR’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ALTAMIR have?
ALTAMIR has 36,512,302 shares outstanding.
What happened to ALTAMIR’s price movement after its last earnings report?
ALTAMIR reported an EPS of -€1.221 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -5.902%.
Which hedge fund is a major shareholder of ALTAMIR?
Currently, no hedge funds are holding shares in FR:LTA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
ALTAMIR
Altamir SCA, previously known as Altamir Amboise, is a Paris-based private equity firm established in 1995. The company employs a dual investment strategy, engaging in both direct investments and fund-of-funds, primarily targeting small and mid-cap companies. For its direct investments, Altamir concentrates on the middle market, executing buyout and growth capital transactions, and shows a particular interest in acquiring underdeveloped segments of larger corporate entities. When investing through other funds, the firm prioritizes private equity funds that specialize in growth capital and leveraged buyouts, often seeking a majority or lead shareholder position within these investments. Its sector focus is broad, encompassing healthcare, technology (including TMT and digital enterprises), various services, retail and distribution, consumer goods, and business and financial services. Within healthcare, Altamir specifically seeks out high-growth potential companies across health services (such as hospitalization, home care, and medical analysis), medical devices, niche pharmaceutical laboratories, and related areas like dermo-cosmetics, galenic development, and services/databases for health organizations. Geographically, Altamir targets unlisted companies across Europe, with a keen focus on Belgium, France, Luxembourg, Switzerland, Monaco, Italy, the Netherlands, Germany, and French-speaking European regions. It also extends its reach to North America (United States and Canada) and major emerging economies including China, India, and Brazil. For smaller and mid-sized companies, the firm prefers Continental Europe, particularly France, Italy, and the Benelux countries, while larger companies are sought across Europe, North America, and the aforementioned emerging markets. Investment sizes range from an enterprise value of €50 million to €500 million for small to mid-cap entities, and €500 million to €3,000 million for larger enterprises. Altamir makes balance sheet investments and frequently collaborates with Apax Partners France and Amboise Investissement, investing and divesting alongside them under identical terms. Furthermore, it directly invests in funds managed or advised by Apax Partners France and Apax Partners LLC. The firm typically aims for an investment horizon of five years before exiting.
Technical Analysis
Eurazeo
―
Wendel SE
―
Tikehau Capital SCA
―
Antin Infrastructure Partners
―
Audacia SA
―
Options Prices
Currently, No data available
---